...
首页> 外文期刊>Medicinal chemistry >Activity of Diosgenyl 2-amino-2-deoxy-β-D-glucopyranoside, its Hydrochloride, and N,N-dialkyl Derivatives Against Non-albicans Candida Isolates
【24h】

Activity of Diosgenyl 2-amino-2-deoxy-β-D-glucopyranoside, its Hydrochloride, and N,N-dialkyl Derivatives Against Non-albicans Candida Isolates

机译:二氧乙烯基2-氨基-2-脱氧 - β -D-吡喃吡喃糖苷,其盐酸盐和N,N-二烷基衍生物对非蛋白酶念珠菌分离株

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Candida albicans belongs to the most common fungal pathogens in humans,but recently an increased proliferation of strains called non-albicans Candida has been reported.Species belonging to this group are often characterised by a reduced susceptibility to antifungalagents.Objective: In view of the emergence of non-albicans Candida and their resistance to available antifungals,an attempt has been made to develop novel effective agents. Biological activities of theN,N-dialkyl diosgenyl glycosides, which were previously synthesized, were determined.Method: Minimum inhibitory concentration (MIC) was determined for group of clinical nonalbicansCandida isolates by serial dilution method in Sabouraud liquid medium. In order to assessthe toxicity towards human cells the minimum haemolytic concentration (MHC) was determinedon human erythrocytes by serial dilution method in phosphoric buffer.Results: The saponins exhibited a strong activity towards clinical isolates of C. glabrata and C.parapsilosis comparable or even stronger than that of conventional antimicrobials. A high rate ofresistance to fluconazole was shown among C. glabrata isolates. Among clinical strains of C.krusei and C. tropicalis, isolates with a decreased susceptibility to saponins were identified. All thetested C. krusei isolates showed resistance to fluconazole, while among C. tropicalis numerousstrains were resistant to all tested azoles. The saponins did not show haemolytic activities at theirmicrobiologically active concentrations.Conclusion: Results of the present work encourage to continue the study on steroidal saponins andtheir potential application for the treatment of candidemia.
机译:背景:念珠菌属于人类中最常见的真菌病原体,但最近已经报道了叫做非蛋白酶念珠菌念珠菌的菌株的增殖增加。属于该组的特征通常是对抗真菌剂的易感性降低的特征。鉴于非阿尔巴文人念珠菌的出现及其对可用抗真菌的抵抗力,试图开发新型有效剂。然后,确定先前合成的N-二烷基二杯糖苷的生物活性。方法:测定最小抑制浓度(MIC),用于通过Sabourauct液体培养基中的连续稀释法测定一组临床诺比甘露西菌分离株。为了评估人体细胞的毒性,通过磷脂中的连续稀释方法确定最低血液解浓度(MHC)。结果:皂苷表现出对C.Glabrata和C.Axapleiss的临床分离株的强烈活性可比或甚至更强比传统的抗微生物剂。在C.Blabrata分离物中显示了对氟康唑的高速率。在C.Krusei和C.Tropicalis的临床菌株中,鉴定了对皂苷易感性降低的分离物。所有的C. Krusei分离物都显示出对氟康唑的抗性,而C.Tropicalis无数型对所有测试的唑尔斯耐药。皂苷未在其霉病活性浓度下显示出溶血活性。结论:目前工作的结果促进继续研究甾体皂苷和潜在申请治疗念珠菌的潜在应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号